Curia Archives | Be Korea-savvy
Curia Appoints Steve Lavezoli as Vice President, Biologics

Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services. “This is an exciting time for our biologics team, and [...]

Curia Receives 2024 CDMO Leadership Award

Curia Receives 2024 CDMO Leadership Award

Curia recognized for its Service in the CDMO industry ALBANY, N.Y., Feb. 05, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a 2024 CDMO Leadership Award in the Service category, Small Pharma group. In its 13th year, the awards are presented by Outsourced Pharma and [...]

Curia Appoints Gerald Auer as Chief Financial Officer

Curia Appoints Gerald Auer as Chief Financial Officer

ALBANY, N.Y., Dec. 15, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join the organization effective Jan. 1, 2024. “I am delighted to welcome Gerald to Curia as we head into the new year,” said Curia [...]

Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India

Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India

ALBANY, N.Y., Dec. 05, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in India by India Pharma Outlook. The full list can be viewed in the November 2023 edition of the India Pharma Outlook magazine. This recognition acknowledges [...]

Curia Expands Biologics Capabilities with Access to Touchlight’s doggybone DNA

Curia Expands Biologics Capabilities with Access to Touchlight’s doggybone DNA

ALBANY, N.Y. and HAMPTON, United Kingdom, July 24 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia and its clients a streamlined means of access to Touchlight’s doggybone DNA (dbDNA). The arrangement expands Curia’s mRNA manufacturing [...]

Curia Wins 2023 Frost & Sullivan Customer Value Leadership Award

Curia Wins 2023 Frost & Sullivan Customer Value Leadership Award

ALBANY, N.Y., June 29 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan. “We are very honored to be recognized with this award, which underlines the hard work and dedication of [...]

Curia Expands Cell Line Development Offering with CHOZN Platform

Curia Expands Cell Line Development Offering with CHOZN Platform

ALBANY, N.Y., June 20 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® GS-/- cell line for production of therapeutic proteins and [...]

Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs

ALBANY, N.Y., March 23 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical industries globally. The collaboration with Corning’s Advanced-Flow™ Reactor (AFR) team includes the first installation of Corning’s G1 production [...]